MiR-212-3p was also found expressed in pancreatic cancer-derived exosomes, inhibiting the expression of the regulatory factor X-associated protein (RFXAP) and consequently decreasing major histocompatibility complex (MHC) class II expression when released into DCs. This evidence concerns the gene RFXAP and familial pancreatic carcinoma.